Canine cancer immunotherapy studies: linking mouse and human

Despite recent major clinical breakthroughs in human cancer immunotherapy including the use of checkpoint inhibitors and engineered T cells, important challenges remain, including determining the sub-populations of patients who will respond and who will experience at times significant toxicities. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jiwon S., Withers, Sita S., Modiano, Jaime F., Kent, Michael S., Chen, Mingyi, Luna, Jesus I., Culp, William T. N., Sparger, Ellen E., Rebhun, Robert B., Monjazeb, Arta M., Murphy, William J., Canter, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171656/
https://www.ncbi.nlm.nih.gov/pubmed/28031824
http://dx.doi.org/10.1186/s40425-016-0200-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171656/
https://www.ncbi.nlm.nih.gov/pubmed/28031824
http://dx.doi.org/10.1186/s40425-016-0200-7

Ejemplares similares